Niva Bupa Health Insurance Company Limited

Niva Bupa Health Insurance Company Limited announced the death of Non-Executive Director Roger William John Davis, aged October 17, 2026, according to a regulatory filing with the National Stock Exchange of India Limited and BSE Limited on October 19, 2026; Davis also ceases to be a member of the Risk Management Committee with effect from the same date.

Niva Bupa Health Insurance Company Ltd announced that India Ratings and Research Private Limited (“India Ratings”) has assigned a rating of IND AAA/Stable with Outlook/Watch to the Company’s proposed sub-debt of Rs 500.00 crores to be raised through the issuance of listed, rated, unsecured, subordinated, redeemable, non-convertible debentures (NCDs), with the instrument type being subordinated debt and the size of the issue being Rs 500.00 crores, representing an assignment of the rating, and no enhancements, assignments, or withdrawals were noted by any other rating agencies.

Niva Bupa Health Insurance Company Limited informed the National Stock Exchange of India Limited and BSE Limited that it received a certificate from KFin Technologies Limited, Registrar to an issue and Share Transfer Agent, for the quarter ended September 30, 2026, pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, and confirmed that no shares of the company were held in physical mode during that period.

Niva Bupa Health Insurance Company Limited will hold a meeting of its Debt Raising Committee on October 9, 2026, to consider and approve the exercise of a call option for Rs 150,00,00,000 of its 1,500 unsecured, subordinated, listed, rated, redeemable, non-convertible debentures bearing ISIN INE995S08010, originally issued on November 15, 2021.

Niva Bupa Health Insurance Company Limited informed the National Stock Exchange of India Limited and BSE Limited that the trading window for dealing in securities of the company will be closed for designated persons and their immediate relatives from Thursday, October 1, 2026, until 48 hours after the unaudited financial results for the quarter and half year ending September 30, 2026, become generally available.

Niva Bupa Health Insurance Company Ltd announced credit rating assignments from multiple agencies, including A.M. Best, which assigned a Financial Strength Rating of A- (Excellent) with a Stable outlook, a Long-Term Issuer Credit Rating of “a-” (Excellent) with a Stable outlook, and an India National Scale Rating (NSR) of aaa.IN (Exceptional) with a Stable outlook; A.M. Best also assigned a Financial Strength Rating of A- (Excellent) with a Stable outlook, a Long-Term Issuer Credit Rating of a- (Excellent) with a Stable outlook, and an India National Scale Rating (NSR) of aaa.IN (Exceptional) with a Stable outlook, alongside assessments of Operating Performance as Adequate, Return-on-Equity of 10.7% for fiscal-year 2026, a Combined Ratio of 102.0% for fiscal-year 2026 (net/net, IFRS 17), a Business Profile of Neutral, and Market Share as ranked third in the standalone health insurance sector, further noting integration with and majority ownership by Bupa Group and expectations for Bupa Group to provide capital support as needed, with additional information available through purchase.

Niva Bupa Health Insurance Company Limited announced changes to its senior management, effective September 16, 2026, including the transition of Mr. Vikas Jain from Chief Investment Officer to Chief Transformation Officer, a role he has held since October 2020, and the appointment of Mr. Karan Bhatia as Chief Investment Officer, bringing over 18 years of experience in the investment domain.

Niva Bupa Health Insurance Company Limited announced the allotment of 4,11,000 equity shares, comprised of 1,92,100 shares under the Niva Bupa Employee Stock Option Plan 2020 and 2,18,900 shares under the Niva Bupa Employee Stock Option Plan 2024, on August 26, 2026, following the exercise of options by eligible grantees; the allotment was approved by the Stakeholders Relationship Committee and increased the company's paid-up equity share capital to Rs 18,49,64,47,030.

Niva Bupa Health Insurance Company Ltd announced that ICRA Limited has reaffirmed its “[ICRA]AAA (Stable)” rating for the Issuer Rating and assigned “[ICRA]AA+(Stable)” ratings to the Subordinated Debt instruments amounting to Rs 500.00 crores and another subordinated debt instrument of 500.00, while also assigning a AAA rating to a Bank Loan of Rs 500 crore with surveillance due in one year; furthermore, ICRA has provided an initial rating of ICRA AA- to Tier II Bonds of Rs 500 Crore, noting that the rating reflects [further details from the text], and reaffirmed the Issuer Rating at [ICRA]AAA(Stable) with a total of -; finally, the rating agency noted that since no instrument is being rated, the Financial Sector Regulator is not applicable.

Net profit of Niva Bupa Health Insurance Company reported to Rs 137.80 crore in the quarter ended June 2026 as against net loss of Rs 91.44 crore during the previous quarter ended June 2025. Sales reported to Rs -2273.72 crore in the quarter ended June 2026 as against Rs 1220.00 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales-2273.721220.00 PL OPM %-8.10-7.62 - PBDT183.74-91.44 LP PBT183.74-91.44 LP NP137.80-91.44 LP Powered by Capital Market - Live